ERBB2 and breast cancer: According to the surface expression of estrogen receptor, progesterone receptor, and human epithelial receptor 2 (HER2), BC can be grouped into four subgroups, that is, luminal A, luminal B, HER2 positive, and triple negative BC (TNBC).